Status unknownNCT05390996Updated May 25, 2022

Implant Stability Changes In Dental Implants Installed By Osseodensification and Conventional Methods

An interventional study of dental implant placement in Dental Implant Stability, sponsored by University of Baghdad. Status unknown at 1 site in Iraq. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-25.

Sponsored by University of Baghdad · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

Registered 4 months after the study started (first participant enrolled Jan 2022, registered May 2022).

Phase: Not applicable
Study type: Interventional
Enrollment: 35
Allocation: Randomized
Ages: 18 Years and older
Sex: All

Study summary

The aim of this study is to evaluate the effect of Osseodensification on implant stability during the healing period The objective of this study is to compare between dental implant stability after osteotomy site preparation using osseodensification technique and conventional drilling technique immediately after implant installation (primary stability) , 6 week after the insertion of implant and 12 weeks later (secondary stability)

Conditions studied

Dental Implant Stability

In context

Lead sponsor

University of Baghdad is the lead sponsor of 164 studies on the registry; 66 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 18 Years and older
Sexes eligible: All
Accepts healthy volunteers: Yes

Inclusion criteria

medically fit patients ≥ 18 years of age including both genders
alveolar ridges of sufficient vertical and horizontal dimensions
bone density less than 850 Hounsfield units (HU) which corresponds to D3-D5 bone density according to Misch bone classification based on preoperative CBCT findings

Exclusion criteria

Exclusion Criteria:

Patients with high bone density (more than 850 HU which corresponds to D1 and D2 according to Misch classification are not suitable for osseodensification.
Patient with severe buccal plate undercut or concavity
Active infection or inflammation in the implant zone
Presence of any uncontrolled systemic diseases.
Any patient need advance treatment such as sinus lifting and bone augmentation.

Study design

Phase: Not applicable
Primary purpose: Treatment
Allocation: Randomized
Intervention model: Parallel assignment
Masking: None (open label)
Enrollment: 35 participants (estimated)

Study arms

Active comparator
condensation drilling technique
condensation of bone (osseodensefecation technique)
Other: dental implant placement
Sham comparator
conventional drilling technique
control group
Other: dental implant placement

Interventions

Otherdental implant placement
dental implant placement by using a different drilling techniques

What researchers measure

Primary outcomes

primary stability
Mean implant stability between different comparators following implants insertion by using resonance frequency analysis scaled from 1 to 100
Time frame: 0 day (baseline)
stability at the dip period
Mean implant stability between different comparators following implants insertion by using resonance frequency analysis scaled from 1 to 100
Time frame: 6 week post surgery
secondary stability
Mean implant stability between different comparators following implants insertion by using resonance frequency analysis scaled from 1 to 100
Time frame: 12 week post surgery

Study locations

1 site

Baghdad University
Baghdad, Babalmatham 00964, Iraq

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on May 25, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT05390996
Lead sponsor: University of Baghdad
Responsible party: Noor Abdulhakeem (Msc.student, University of Baghdad) — Principal investigator
First posted: May 25, 2022
Start date: Jan 5, 2022
Primary completion: Sep 1, 2022 (estimated)
Completion: Jan 2023 (estimated)
Last update: May 25, 2022

Study contacts

Salwan Y Bede, BDS,FIMBS

principal investigator · University of Bagh

Oversight

FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

University of Baghdad

Start the discussion